Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis

NCT ID: NCT03901794

Last Updated: 2019-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-06

Study Completion Date

2018-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Relationship between hemodynamic change and fluid removed during hemodialysis measured by non-invasive monitor

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

By applying non-invasive hemodynamic monitors (ex. ClearSight, I-COM), the trends of mean arterial pressure (MAP), stroke volume (SV), cardiac index (CI) and calculated systemic vascular resistance (SVR) were collected along with volume removal by hemodialysis on ESRD patients. All data were compared and analyzed to detect the sequential body volume status as well as the autonomic responses during hemodialysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis Complication Hemodialysis-Induced Symptom

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With Clear Sight

record and observe the data including SVI, CI, SVR with clearSight during hemodialysis

Non-invasive hemodynamic monitor

Intervention Type DEVICE

MAP, HR, CO, SVI, from Non-invasive hemodynamic monitor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-invasive hemodynamic monitor

MAP, HR, CO, SVI, from Non-invasive hemodynamic monitor

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Patients who were schedured with regular hemodialysis for end-stage renal disease.

Exclusion Criteria

1. Emergent hemodialysis
2. Medical conditions with poor peripheral circulation such as Raynaud's disease or PAOD
3. Skin defects or wounds over area to be applied for measurement (Wrist and fingers)
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ST Chen

Role: STUDY_CHAIR

National Taiwan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Lai CJ, Shih CC, Huang HH, Chien MH, Wu MS, Cheng YJ. Detecting Volemic, Cardiac, and Autonomic Responses From Hypervolemia to Normovolemia via Non-Invasive ClearSight Hemodynamic Monitoring During Hemodialysis: An Observational Investigation. Front Physiol. 2022 Apr 28;13:775631. doi: 10.3389/fphys.2022.775631. eCollection 2022.

Reference Type DERIVED
PMID: 35574491 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201702064RIPB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.